BRD2 and melanoma: Examinations of Human Protein Atlas datasets revealed that overexpression of BET family BRD proteins (i.e., BRD2 and BRD3), BRD9, BRD7, and EZH2 were associated with relatively poor three-year survival in melanoma patients.